OINDPnews


Copley Scientific banner

Business

MannKind looking to raise $370 million for continued development of Afrezza

MannKind Corporation has announced a proposed offer of senior secured discount notes, due 2017, that would yield approximately $370 million. The company says that it would use the money to complete Phase 3 clinical trials of its Afrezza inhaled insulin, to prepare for commercialization of the product, and for work on its manufacturing plant in Danbury, CT, among other … [Read more...] about MannKind looking to raise $370 million for continued development of Afrezza

TOBI Podhaler DPI launched in UK

Novartis has launched its TOBI Podhaler tobramycin dry powder inhaler in the UK. The DPI, for the treatment of P. aeruginosa infections in cystic fibrosis patients. The CF Trust responded to the launch on its website, noting "This is the first ever antibiotic pod haler and is a development the CF Trust welcomes." Read a brief article. … [Read more...] about TOBI Podhaler DPI launched in UK

Southwest Research Institute gets $4.4 million for development of intranasal cyanide antidote

The US Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA) has awarded a $4.4 million contract to Texas-based Southwest Research Institute (SwRI), an independent applied research and development organization, for development of an intranasal cyanide antidote. The only treatments for cyanide poisoning currently … [Read more...] about Southwest Research Institute gets $4.4 million for development of intranasal cyanide antidote

Sun Pharma says it will file IND for Starhaler in 2012

During its presentation at the 2011 Morgan Stanley Global Healthcare Conference on September 14, Sun Pharma Advanced Research Company (SPARC) provided a detailed report on the development of its Starhaler dry powder inhaler and announced that it plans to file an investigational new drug (IND) application in the US in 2012. The company, which co-developed the device … [Read more...] about Sun Pharma says it will file IND for Starhaler in 2012

Hearing in Proveris/Innova case delayed by Innova bankruptcy

Just prior to a scheduled hearing to determine sanctions in the Proveris Scientic vs. InnovaSystems case that was scheduled for September 6, 2011, InnovaSystems filed for bankruptcy, indefinitely delaying the hearing. The petition for Chapter 11 bankruptcy filed on September 2 in New Jersey lists two law firms that represented Innova in the patent infringement case as … [Read more...] about Hearing in Proveris/Innova case delayed by Innova bankruptcy

Hi-Tech Pharmacal’s fluticasone nasal spray sales more than double

First quarter sales of Hi-Tech Pharmacal's fluticasone proprionate nasal spray rose from $11,700,000 in 2010 to $26,200,000 this year, the company has announced, continuing a rapid increase in sales since the product was introduced. First quarter earnings rose 59% overall, which is mostly attributable to the increase in nasal spray sales. The fluticasone … [Read more...] about Hi-Tech Pharmacal’s fluticasone nasal spray sales more than double

Iran phases out CFC inhalers

On September 5, a ceremony in Tehran marked the occasion as Iran officially phased out CFC-based metered dose inhalers (MDIs) in accordance with the Montreal Protocol, becoming the first country in the Asia-Pacific region to do so. The event, attended by government officials, clinicians, and representatives of international organizations, celebrated the closing of … [Read more...] about Iran phases out CFC inhalers